Obstetrics & Gynecology · Baton Rouge, LA
NPI
1861478406
Since 2005
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
500 Rue de la Vie St, Suite 100
Baton Rouge, LA, 70817
Phone (225) 201-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,169 services
Medicare patients, 2024
265
Average age 72
Drug cost, 2024
$71K
723 prescriptions
Company payments, 2025
$89.74
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wendy Holden-Parker was code 77067 (mammography), 199 times for 199 patients. In total Wendy Holden-Parker billed 1,169 services in 47 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 77067 Mammography | Office | 199 | 199 | $107.52 | $21K |
| 77063 Mammography | Office | 198 | 198 | $44.78 | $8,867 |
| G0101 Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 164 | 164 | $34.01 | $5,577 |
| Q0091 Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 142 | 142 | $37.64 | $5,345 |
| 99214 Office E&M - Established | Office | 122 | 107 | $72.43 | $8,837 |
| 77080 Standard X-ray | Office | 66 | 66 | $32.65 | $2,155 |
| 87481 Infectious Agent Detection by DNA/RNA | Office | 36 | 19 | $34.39 | $1,238 |
| 99213 Office E&M - Established | Office | 31 | 27 | $46.49 | $1,441 |
| 36415 Venipuncture Blood Collection | Office | 30 | 28 | $8.65 | $260 |
| 87661 Infectious Agent Detection by DNA/RNA | Office | 20 | 20 | $32.88 | $658 |
| G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 20 | 19 | $32.78 | $656 |
| 81513 Infectious Agent Detection by DNA/RNA | Office | 19 | 19 | $139.78 | $2,656 |
| 76830 Ultrasound - Abdomen and Pelvis | Office | 15 | 13 | $68.44 | $1,027 |
| 77066 Mammography | Office | 14 | 14 | $101.17 | $1,416 |
| 82306 Clinical Chemistry | Office | 13 | 13 | $29.01 | $377 |
By year: 2022 $58K for 948 services; 2023 $67K for 1,074 services; 2024 $67K for 1,169 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87481 Infectious Agent Detection by DNA/RNA | 36 | 19 | $34.39 | $1,238 |
| 36415 Venipuncture Blood Collection | 30 | 28 | $8.65 | $260 |
| 87661 Infectious Agent Detection by DNA/RNA | 20 | 20 | $32.88 | $658 |
| 81513 Infectious Agent Detection by DNA/RNA | 19 | 19 | $139.78 | $2,656 |
| 82306 Clinical Chemistry | 13 | 13 | $29.01 | $377 |
Medicare prescription drug claims, 2024
In 2024, the drug Wendy Holden-Parker prescribed most often to Medicare patients was Estradiol, with 230 prescriptions and refills. In total Wendy Holden-Parker wrote 723 Medicare prescriptions that cost $71K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Estradiol Generic | 230 | 559 | 91 | $19K |
| Estradiol (Twice Weekly) Estradiol | 126 | 223 | 32 | $12K |
| Dotti Estradiol | 71 | 125 | 20 | $9,265 |
| Yuvafem Estradiol | 32 | 77 | 12 | $5,089 |
| Progesterone Progesterone, Micronized | 28 | 60 | Under 11 | $1,038 |
| Valacyclovir Valacyclovir Hcl | 26 | 38 | Under 11 | $511 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 18 | 19 | 16 | $347 |
| Medroxyprogesterone Acetate Generic | 17 | 45 | Under 11 | $179 |
| Premarin Estrogens, Conjugated | 14 | 29 | Under 11 | $5,071 |
| Lo Loestrin Fe Norethindrone-E.Estradiol-Iron | 11 | 11 | Under 11 | $1,986 |
Brand drugs: 113 claims; generic drugs: 610 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wendy Holden-Parker $89.74 ($89.74 in general payments such as food, travel and fees) from 5 companies. The largest payer was Millicent US Inc with $19.27.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.